APA aipamena

Occhipinti, M., Falcone, R., Onesti, C. E., Botticelli, A., Mazzuca, F., Marchetti, P., & Lauro, S. (2017). Crizotinib plus radiotherapy in brain oligoprogressive NSCLC ROS1 rearranged and PD-L1 strong. J Thorac Dis.

Chicago Style aipamena

Occhipinti, Mario, Rosa Falcone, Concetta Elisa Onesti, Andrea Botticelli, Federica Mazzuca, Paolo Marchetti, and Salvatore Lauro. "Crizotinib Plus Radiotherapy in Brain Oligoprogressive NSCLC ROS1 Rearranged and PD-L1 Strong." J Thorac Dis 2017.

MLA aipamena

Occhipinti, Mario, et al. "Crizotinib Plus Radiotherapy in Brain Oligoprogressive NSCLC ROS1 Rearranged and PD-L1 Strong." J Thorac Dis 2017.